30 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
for mRNA Medicines (AMM). With the founding of the Alliance for mRNA Medicines, our community is now poised to champion scientific standards and public
8-K
EX-99.1
3k68o ms25rd990ml
10 Nov 21
Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022
4:09pm
424B4
ncweicrvtl6a6 dmja
13 Sep 21
Prospectus supplement with pricing info
4:16pm
DRS
gadbss7hb3ynkjg
26 Aug 21
Draft registration statement
12:00am
DEF 14A
ru98xbz
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
1g868lr2 otg
9 Apr 21
Preliminary proxy
4:16pm
424B4
6qajdi7e
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
ka8a6bzvv
25 Mar 21
Draft registration statement
12:00am
10-K
p2dzy lv4l0
22 Mar 21
Annual report
4:22pm
8-K
EX-10.1
zr1tl1jq
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.2
kz6zprj6t
23 Nov 20
Registration of securities for employees
5:06pm
424B4
dtdj56
23 Nov 20
Prospectus supplement with pricing info
4:36pm